cellular process (GO:0009987) | 0.26 | 34 | EYA4, SGCD, VCL, MYH6, FKTN, DMD, PLN, TNNT2, TPM1, MYPN, RAF1, RBM20, CRYAB, LMNA, MYH7, ACTC1, PSEN1, TNNI3, ABCC9, BAG3, SDHA, PRDM16, SCN5A, MYBPC3, NEXN, ACTN2, CSRP3, TNNC1, LAMA4, DES, DSG2, TTN, LDB3, PSEN2 |
single-organism process (GO:0044699) | 0.48 | 33 | EYA4, NEXN, SGCD, VCL, MYH6, FKTN, DMD, PLN, TNNT2, TPM1, MYPN, RAF1, RBM20, CRYAB, LMNA, MYH7, ACTC1, PSEN1, TNNI3, SDHA, PRDM16, SCN5A, MYBPC3, BAG3, ACTN2, CSRP3, TNNC1, LAMA4, DES, DSG2, TTN, LDB3, ABCC9 |
biological regulation (GO:0065007) | 0.39 | 32 | EYA4, TPM1, VCL, GATAD1, TMPO, FKTN, DMD, PLN, TNNT2, MYH6, BAG3, RAF1, RBM20, CRYAB, LMNA, MYH7, ACTC1, PSEN1, TNNI3, ABCC9, PRDM16, SCN5A, MYBPC3, NEXN, ACTN2, CSRP3, TNNC1, LAMA4, DES, DSG2, TTN, PSEN2 |
regulation of biological process (GO:0050789) | 0.45 | 32 | EYA4, TPM1, VCL, GATAD1, TMPO, FKTN, DMD, PLN, TNNT2, MYH6, NEXN, RAF1, RBM20, CRYAB, LMNA, MYH7, ACTC1, PSEN1, TNNI3, ABCC9, PRDM16, SCN5A, MYBPC3, BAG3, ACTN2, CSRP3, TTN, LAMA4, DES, DSG2, TNNC1, PSEN2 |
single-organism cellular process (GO:0044763) | 0.65 | 31 | TPM1, SGCD, VCL, MYH6, FKTN, DMD, PLN, TNNT2, MYPN, RAF1, CRYAB, LMNA, MYH7, ACTC1, PSEN1, TNNI3, BAG3, SDHA, PRDM16, SCN5A, MYBPC3, NEXN, ACTN2, CSRP3, TNNC1, LAMA4, DES, DSG2, TTN, LDB3, ABCC9 |
developmental process (GO:0032502) | 1.36 | 29 | EYA4, SGCD, VCL, DSG2, FKTN, DMD, PLN, TNNT2, TPM1, BAG3, RAF1, RBM20, CRYAB, LMNA, MYH7, ACTC1, PSEN1, TNNI3, SDHA, PRDM16, SCN5A, MYBPC3, NEXN, ACTN2, CSRP3, TNNC1, LAMA4, MYH6, TTN |
regulation of cellular process (GO:0050794) | 0.5 | 29 | EYA4, TPM1, VCL, GATAD1, TMPO, FKTN, DMD, PLN, TNNT2, MYH6, BAG3, RAF1, RBM20, CRYAB, LMNA, ACTC1, PSEN1, ABCC9, PRDM16, SCN5A, MYBPC3, NEXN, ACTN2, CSRP3, TNNC1, LAMA4, DSG2, TTN, PSEN2 |
single-organism developmental process (GO:0044767) | 1.49 | 26 | EYA4, SGCD, VCL, FKTN, DMD, TNNT2, TPM1, BAG3, RAF1, RBM20, CRYAB, LMNA, MYH7, ACTC1, PSEN1, TNNI3, PRDM16, SCN5A, MYBPC3, NEXN, ACTN2, CSRP3, TNNC1, LAMA4, MYH6, TTN |
anatomical structure development (GO:0048856) | 1.58 | 24 | EYA4, SGCD, SDHA, DSG2, FKTN, DMD, PLN, SCN5A, TPM1, RBM20, RAF1, CRYAB, LMNA, MYH7, PSEN1, TNNI3, BAG3, PRDM16, NEXN, ACTN2, CSRP3, TTN, LAMA4, MYH6 |
multicellular organismal process (GO:0032501) | 1.45 | 23 | EYA4, SGCD, VCL, MYH6, DMD, PLN, TNNT2, TPM1, RAF1, CRYAB, MYH7, ACTC1, PSEN1, TNNI3, PRDM16, SCN5A, MYBPC3, ACTN2, CSRP3, TNNC1, DES, DSG2, TTN |
cellular component organization (GO:0016043) | 1.24 | 22 | EYA4, SGCD, VCL, MYH6, DMD, PLN, TNNT2, TPM1, MYPN, LMNA, CRYAB, RAF1, ACTC1, PSEN1, PRDM16, ACTN2, CSRP3, TTN, LAMA4, DES, DSG2, LDB3 |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 22 | EYA4, SGCD, VCL, MYH6, DMD, PLN, TNNT2, TPM1, MYPN, LMNA, CRYAB, RAF1, ACTC1, PSEN1, PRDM16, ACTN2, CSRP3, TTN, LAMA4, DES, DSG2, LDB3 |
system process (GO:0003008) | 2.3 | 20 | ACTN2, PLN, TPM1, TNNT2, MYH7, CSRP3, TNNC1, DES, EYA4, ACTC1, SGCD, MYH6, TNNI3, TTN, VCL, PSEN1, CRYAB, SCN5A, MYBPC3, DMD |
response to stimulus (GO:0050896) | 1.22 | 18 | PLN, CSRP3, CRYAB, TNNT2, RAF1, EYA4, TNNC1, ACTC1, TPM1, PSEN1, TTN, DSG2, LMNA, PSEN2, SCN5A, DMD, ABCC9, BAG3 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 18 | PLN, TPM1, TNNT2, MYH6, MYH7, TNNC1, LAMA4, DES, CSRP3, PSEN1, LMNA, TNNI3, DSG2, PRDM16, ABCC9, SCN5A, DMD, MYBPC3 |
muscle system process (GO:0003012) | 4.18 | 17 | ACTN2, PLN, CRYAB, TNNT2, MYH7, CSRP3, TNNC1, DES, ACTC1, TPM1, MYH6, TNNI3, TTN, VCL, SCN5A, DMD, MYBPC3 |
muscle contraction (GO:0006936) | 4.37 | 16 | ACTN2, CSRP3, CRYAB, TNNT2, MYH7, TTN, ACTC1, DES, TPM1, MYH6, TNNI3, TNNC1, VCL, SCN5A, DMD, MYBPC3 |
regulation of biological quality (GO:0065008) | 1.68 | 15 | ACTN2, PLN, TPM1, TNNT2, DSG2, MYH7, TNNC1, CSRP3, MYH6, TNNI3, PSEN1, RAF1, SCN5A, DMD, BAG3 |
actin filament-based process (GO:0030029) | 3.94 | 15 | ACTN2, TPM1, TNNT2, MYH7, TNNC1, DES, ACTC1, CSRP3, MYH6, TNNI3, TTN, MYPN, LDB3, DMD, MYBPC3 |
regulation of metabolic process (GO:0019222) | 1.02 | 15 | ACTN2, CSRP3, CRYAB, MYH6, TTN, ACTC1, EYA4, TMPO, GATAD1, FKTN, RAF1, PSEN1, PRDM16, DMD, RBM20 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 15 | ACTN2, CSRP3, CRYAB, MYH6, TTN, ACTC1, EYA4, TMPO, GATAD1, FKTN, RAF1, PSEN1, PRDM16, DMD, RBM20 |
negative regulation of biological process (GO:0048519) | 1.33 | 15 | ACTN2, PLN, CRYAB, FKTN, CSRP3, ACTC1, TPM1, PSEN1, LMNA, RAF1, VCL, PRDM16, PSEN2, DMD, BAG3 |
regulation of molecular function (GO:0065009) | 1.78 | 15 | ACTN2, PLN, CRYAB, TNNT2, TNNC1, TPM1, PSEN1, TNNI3, TTN, MYH6, RAF1, PSEN2, DMD, MYBPC3, BAG3 |
regulation of localization (GO:0032879) | 1.94 | 15 | ACTN2, PLN, CRYAB, TNNT2, RAF1, TNNC1, LAMA4, TPM1, VCL, DSG2, LMNA, SCN5A, DMD, MYBPC3, NEXN |
organelle organization (GO:0006996) | 2.02 | 14 | ACTN2, CSRP3, CRYAB, RAF1, TTN, ACTC1, DES, TPM1, PSEN1, LMNA, MYH6, LDB3, MYPN, DMD |
regulation of primary metabolic process (GO:0080090) | 1.08 | 14 | ACTN2, CSRP3, CRYAB, MYH6, TTN, EYA4, PSEN1, GATAD1, FKTN, RAF1, TMPO, PRDM16, DMD, RBM20 |
regulation of system process (GO:0044057) | 3.53 | 14 | PLN, TPM1, TNNT2, MYH7, TNNC1, DES, CSRP3, DSG2, TNNI3, MYH6, ABCC9, SCN5A, DMD, MYBPC3 |
regulation of catalytic activity (GO:0050790) | 1.97 | 14 | ACTN2, PLN, CRYAB, TNNT2, TNNC1, TPM1, MYH6, TNNI3, TTN, PSEN1, RAF1, PSEN2, MYBPC3, BAG3 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 14 | ACTN2, CSRP3, CRYAB, MYH6, TTN, EYA4, PSEN1, GATAD1, FKTN, RAF1, TMPO, PRDM16, DMD, RBM20 |
cellular metabolic process (GO:0044237) | 0.69 | 14 | ACTN2, CRYAB, FKTN, MYH7, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16, PSEN2, DMD, RBM20, SDHA |
movement of cell or subcellular component (GO:0006928) | 2.61 | 14 | ACTN2, TPM1, TNNT2, MYH7, TNNC1, DES, ACTC1, MYH6, TNNI3, TTN, VCL, PSEN1, DMD, MYBPC3 |
organic substance metabolic process (GO:0071704) | 0.63 | 14 | ACTN2, CRYAB, FKTN, MYH7, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16, PSEN2, DMD, RBM20, SDHA |
animal organ development (GO:0048513) | 2.53 | 14 | RBM20, CSRP3, SGCD, FKTN, MYH7, CRYAB, PSEN1, LMNA, TNNI3, RAF1, MYH6, PRDM16, DMD, BAG3 |
metabolic process (GO:0008152) | 0.58 | 14 | ACTN2, CRYAB, FKTN, MYH7, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16, PSEN2, DMD, RBM20, SDHA |
negative regulation of cellular process (GO:0048523) | 1.41 | 14 | ACTN2, CSRP3, TPM1, FKTN, ACTC1, CRYAB, PSEN1, LMNA, RAF1, VCL, PRDM16, PSEN2, DMD, BAG3 |
primary metabolic process (GO:0044238) | 0.69 | 13 | ACTN2, CRYAB, FKTN, MYH7, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16, PSEN2, RBM20, SDHA |
single-organism organelle organization (GO:1902589) | 2.68 | 13 | ACTN2, CSRP3, CRYAB, RAF1, TTN, ACTC1, DES, TPM1, MYPN, LMNA, MYH6, LDB3, DMD |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 13 | TPM1, TNNT2, MYH6, MYH7, TNNC1, ACTC1, EYA4, VCL, TNNI3, TTN, PSEN1, SCN5A, MYBPC3 |
single-multicellular organism process (GO:0044707) | 1.78 | 13 | PLN, CSRP3, TPM1, SCN5A, DSG2, TNNC1, ACTC1, EYA4, MYH6, RAF1, PSEN1, PRDM16, DMD |
cellular developmental process (GO:0048869) | 1.82 | 13 | ACTN2, SGCD, LMNA, TTN, LAMA4, CSRP3, PSEN1, TNNI3, RAF1, MYH6, PRDM16, DMD, NEXN |
muscle filament sliding (GO:0030049) | 6.09 | 12 | ACTN2, TPM1, TNNT2, MYH7, TNNC1, DES, ACTC1, MYH6, TNNI3, TTN, DMD, MYBPC3 |
regulation of cellular component movement (GO:0051270) | 3.08 | 12 | PLN, TPM1, TNNT2, RAF1, TNNC1, LAMA4, VCL, DSG2, LMNA, SCN5A, MYBPC3, NEXN |
cytoskeleton organization (GO:0007010) | 3.22 | 12 | ACTN2, CSRP3, CRYAB, LMNA, TTN, ACTC1, DES, TPM1, MYH6, RAF1, MYPN, LDB3 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 12 | ACTN2, CRYAB, FKTN, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16, PSEN2, DMD, RBM20 |
regulation of gene expression (GO:0010468) | 1.37 | 12 | CSRP3, CRYAB, MYH6, ACTC1, EYA4, TMPO, GATAD1, RAF1, PSEN1, PRDM16, DMD, RBM20 |
regulation of heart contraction (GO:0008016) | 4.35 | 12 | PLN, TPM1, TNNT2, MYH7, DES, CSRP3, DSG2, TNNI3, MYH6, ABCC9, SCN5A, DMD |
regulation of response to stimulus (GO:0048583) | 1.54 | 12 | ACTN2, PLN, CRYAB, FKTN, MYH7, TNNC1, PSEN1, LMNA, RAF1, PRDM16, DMD, BAG3 |
macromolecule metabolic process (GO:0043170) | 0.83 | 12 | ACTN2, CRYAB, FKTN, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16, PSEN2, DMD, RBM20 |
striated muscle contraction (GO:0006941) | 5.37 | 12 | TPM1, TNNT2, MYH7, TTN, ACTC1, CSRP3, MYH6, TNNI3, TNNC1, SCN5A, DMD, MYBPC3 |
actin filament-based movement (GO:0030048) | 5.54 | 12 | ACTN2, TPM1, TNNT2, MYH7, TNNC1, DES, ACTC1, MYH6, TNNI3, TTN, MYBPC3, DMD |
actin-myosin filament sliding (GO:0033275) | 6.09 | 12 | ACTN2, TPM1, TNNT2, MYH7, TNNC1, DES, ACTC1, MYH6, TNNI3, TTN, DMD, MYBPC3 |
cellular component assembly (GO:0022607) | 2.14 | 12 | ACTN2, PLN, CRYAB, TNNT2, TTN, ACTC1, CSRP3, PSEN1, VCL, MYH6, RAF1, DMD |
regulation of blood circulation (GO:1903522) | 4.05 | 12 | PLN, TPM1, TNNT2, MYH7, DES, CSRP3, MYH6, TNNI3, DSG2, ABCC9, SCN5A, DMD |
positive regulation of biological process (GO:0048518) | 1.2 | 12 | ACTN2, TPM1, SCN5A, LMNA, ACTC1, CSRP3, PSEN1, RAF1, PRDM16, PSEN2, DMD, RBM20 |
actin-mediated cell contraction (GO:0070252) | 5.88 | 12 | ACTN2, TPM1, TNNT2, MYH7, TNNC1, DES, ACTC1, MYH6, TNNI3, TTN, DMD, MYBPC3 |
cardiac muscle contraction (GO:0060048) | 5.88 | 12 | TPM1, TNNT2, MYH7, TNNC1, ACTC1, CSRP3, MYH6, TNNI3, TTN, SCN5A, MYBPC3, DMD |
localization (GO:0051179) | 1.4 | 12 | ACTN2, PLN, CSRP3, SCN5A, LMNA, TTN, VCL, ABCC9, PSEN1, RAF1, PSEN2, DMD |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 11 | ACTN2, EYA4, MYH6, CSRP3, PSEN1, GATAD1, RAF1, TMPO, PRDM16, DMD, RBM20 |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 11 | ACTN2, CSRP3, EYA4, MYH6, GATAD1, PSEN1, FKTN, RAF1, TMPO, PRDM16, DMD |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 11 | ACTN2, EYA4, MYH6, CSRP3, PSEN1, GATAD1, RAF1, TMPO, PRDM16, DMD, RBM20 |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 11 | ACTN2, EYA4, MYH6, CSRP3, PSEN1, GATAD1, RAF1, TMPO, PRDM16, DMD, RBM20 |
regulation of biosynthetic process (GO:0009889) | 1.37 | 11 | ACTN2, EYA4, PRDM16, CSRP3, PSEN1, GATAD1, RAF1, TMPO, FKTN, MYH6, DMD |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 11 | ACTN2, EYA4, MYH6, CSRP3, PSEN1, GATAD1, FKTN, RAF1, TMPO, PRDM16, DMD |
signal transduction (GO:0007165) | 1.28 | 11 | ACTN2, PLN, CRYAB, RAF1, PSEN1, ABCC9, MYH6, LMNA, PSEN2, DMD, BAG3 |
tissue morphogenesis (GO:0048729) | 3.87 | 11 | TPM1, TNNT2, MYH6, MYH7, TTN, ACTC1, VCL, TNNI3, TNNC1, PSEN1, MYBPC3 |
positive regulation of cellular process (GO:0048522) | 1.3 | 11 | ACTN2, TPM1, SCN5A, LMNA, CSRP3, PSEN1, RAF1, PRDM16, PSEN2, DMD, RBM20 |
regulation of hydrolase activity (GO:0051336) | 2.53 | 10 | ACTN2, PLN, CRYAB, TNNT2, TNNC1, TPM1, MYH6, TNNI3, RAF1, MYBPC3 |
cellular protein metabolic process (GO:0044267) | 1.63 | 10 | ACTN2, CRYAB, FKTN, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16, PSEN2 |
regulation of muscle contraction (GO:0006937) | 4.75 | 10 | PLN, TPM1, TNNT2, MYH7, TNNC1, DSG2, TNNI3, SCN5A, DMD, MYBPC3 |
protein metabolic process (GO:0019538) | 1.45 | 10 | ACTN2, CRYAB, FKTN, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16, PSEN2 |
transport (GO:0006810) | 1.51 | 10 | ACTN2, PLN, SCN5A, RAF1, TTN, VCL, ABCC9, PSEN1, LMNA, PSEN2 |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 10 | EYA4, PRDM16, CSRP3, PSEN1, GATAD1, RAF1, TMPO, FKTN, MYH6, DMD |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 10 | ACTN2, EYA4, MYH6, CSRP3, PSEN1, GATAD1, RAF1, TMPO, PRDM16, DMD |
regulation of signaling (GO:0023051) | 1.72 | 10 | ACTN2, PLN, FKTN, PSEN1, LMNA, TNNI3, RAF1, PRDM16, ABCC9, DMD |
regulation of muscle system process (GO:0090257) | 4.51 | 10 | PLN, TPM1, TNNT2, MYH7, TNNC1, DSG2, TNNI3, SCN5A, DMD, MYBPC3 |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 10 | ACTN2, EYA4, MYH6, CSRP3, PSEN1, GATAD1, RAF1, TMPO, PRDM16, DMD |
response to chemical (GO:0042221) | 1.98 | 10 | PLN, CRYAB, TNNT2, TTN, ACTC1, TPM1, DSG2, TNNC1, LMNA, SCN5A |
establishment of localization (GO:0051234) | 1.48 | 10 | ACTN2, PLN, SCN5A, RAF1, TTN, VCL, ABCC9, PSEN1, LMNA, PSEN2 |
macromolecular complex subunit organization (GO:0043933) | 2.14 | 9 | ACTN2, PLN, CRYAB, TNNT2, RAF1, TTN, EYA4, PRDM16, DMD |
cardiac muscle tissue morphogenesis (GO:0055008) | 5.8 | 9 | TPM1, TNNT2, MYH7, TTN, ACTC1, MYH6, TNNI3, TNNC1, MYBPC3 |
regulation of actin filament-based process (GO:0032970) | 3.97 | 9 | ACTN2, PLN, TPM1, TNNT2, TNNC1, CSRP3, DSG2, SCN5A, MYBPC3 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 9 | EYA4, RAF1, MYH7, PSEN1, MYH6, PRDM16, PSEN2, DMD, RBM20 |
cellular protein modification process (GO:0006464) | 1.79 | 9 | ACTN2, CRYAB, FKTN, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16 |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 9 | EYA4, MYH6, CSRP3, PSEN1, GATAD1, RAF1, TMPO, PRDM16, DMD |
macromolecule modification (GO:0043412) | 1.73 | 9 | ACTN2, CRYAB, FKTN, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 9 | EYA4, RAF1, MYH7, PSEN1, MYH6, PRDM16, PSEN2, DMD, RBM20 |
protein modification process (GO:0036211) | 1.79 | 9 | ACTN2, CRYAB, FKTN, TTN, EYA4, PSEN1, RAF1, MYH6, PRDM16 |
muscle tissue morphogenesis (GO:0060415) | 5.62 | 9 | TPM1, TNNT2, MYH7, TNNC1, ACTC1, MYH6, TNNI3, TTN, MYBPC3 |
response to abiotic stimulus (GO:0009628) | 2.8 | 8 | CRYAB, LMNA, TTN, CSRP3, RAF1, PSEN2, DMD, BAG3 |
single-organism metabolic process (GO:0044710) | 1.63 | 8 | ACTN2, CRYAB, RAF1, MYH7, PSEN1, MYH6, FKTN, SDHA |
regulation of cell death (GO:0010941) | 2.43 | 8 | ACTN2, CRYAB, RAF1, ACTC1, PSEN1, LMNA, PSEN2, BAG3 |
actomyosin structure organization (GO:0031032) | 5.4 | 8 | ACTN2, TPM1, TTN, ACTC1, CSRP3, MYPN, MYH6, LDB3 |
regulation of cellular localization (GO:0060341) | 3.03 | 8 | ACTN2, PLN, CRYAB, TNNT2, TNNC1, LMNA, DMD, MYBPC3 |
regulation of developmental process (GO:0050793) | 2.1 | 8 | TPM1, LMNA, LAMA4, CSRP3, MYH6, PSEN1, PRDM16, DMD |
regulation of transport (GO:0051049) | 2.24 | 8 | ACTN2, PLN, CRYAB, TNNT2, TNNC1, SCN5A, DMD, MYBPC3 |
cell development (GO:0048468) | 3.28 | 8 | ACTN2, SGCD, TTN, PSEN1, MYH6, LMNA, DMD, NEXN |
regulation of programmed cell death (GO:0043067) | 2.49 | 8 | ACTN2, CRYAB, RAF1, ACTC1, PSEN1, LMNA, PSEN2, BAG3 |
actin cytoskeleton organization (GO:0030036) | 4.1 | 8 | ACTN2, TPM1, TTN, ACTC1, CSRP3, MYPN, MYH6, LDB3 |
regulation of cellular component organization (GO:0051128) | 2.01 | 8 | ACTN2, CRYAB, RAF1, TPM1, PSEN1, LMNA, DMD, NEXN |
regulation of signal transduction (GO:0009966) | 1.84 | 8 | ACTN2, PLN, PRDM16, PSEN1, LMNA, RAF1, FKTN, DMD |
response to stress (GO:0006950) | 1.8 | 8 | CRYAB, RAF1, TPM1, PSEN1, ABCC9, LMNA, PSEN2, EYA4 |
positive regulation of molecular function (GO:0044093) | 2.23 | 8 | ACTN2, TPM1, TNNT2, PSEN1, RAF1, PSEN2, DMD, MYBPC3 |
regulation of cell communication (GO:0010646) | 1.73 | 8 | ACTN2, PLN, PRDM16, PSEN1, LMNA, RAF1, FKTN, DMD |
regulation of apoptotic process (GO:0042981) | 2.5 | 8 | ACTN2, CRYAB, RAF1, ACTC1, PSEN1, LMNA, PSEN2, BAG3 |
muscle cell development (GO:0055001) | 5.29 | 7 | ACTN2, SGCD, TTN, MYH6, LMNA, DMD, NEXN |
cellular response to stimulus (GO:0051716) | 1.97 | 7 | CRYAB, SCN5A, EYA4, PSEN1, TPM1, LMNA, BAG3 |
regulation of ATPase activity (GO:0043462) | 5.59 | 7 | PLN, TPM1, TNNT2, TNNC1, MYH6, TNNI3, MYBPC3 |
protein complex subunit organization (GO:0071822) | 2.6 | 7 | ACTN2, PLN, CRYAB, TNNT2, TTN, RAF1, DMD |
response to external stimulus (GO:0009605) | 2.55 | 7 | CSRP3, LMNA, TTN, RAF1, ABCC9, DMD, BAG3 |
ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.07 | 7 | TPM1, TNNT2, MYH7, TNNC1, MYH6, TNNI3, MYBPC3 |
negative regulation of cell death (GO:0060548) | 2.95 | 7 | CRYAB, RAF1, ACTC1, PSEN1, LMNA, PSEN2, BAG3 |
protein complex assembly (GO:0006461) | 2.78 | 7 | ACTN2, PLN, CRYAB, TNNT2, TTN, RAF1, DMD |
muscle organ development (GO:0007517) | 4.98 | 7 | CSRP3, LMNA, CRYAB, MYH6, SGCD, FKTN, DMD |
macromolecular complex assembly (GO:0065003) | 2.55 | 7 | ACTN2, PLN, CRYAB, TNNT2, TTN, RAF1, DMD |
regulation of heart rate (GO:0002027) | 5.29 | 7 | PLN, TPM1, SCN5A, MYH7, DSG2, MYH6, DMD |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 7 | ACTN2, CRYAB, MYH7, TTN, EYA4, MYH6, RAF1 |
negative regulation of apoptotic process (GO:0043066) | 3.04 | 7 | CRYAB, RAF1, ACTC1, PSEN1, LMNA, PSEN2, BAG3 |
negative regulation of molecular function (GO:0044092) | 2.74 | 7 | ACTN2, PLN, CRYAB, TNNT2, PSEN1, TNNI3, RAF1 |
phosphorus metabolic process (GO:0006793) | 2.15 | 7 | ACTN2, CRYAB, MYH7, TTN, EYA4, MYH6, RAF1 |
muscle structure development (GO:0061061) | 4.96 | 7 | CSRP3, LMNA, CRYAB, MYH6, SGCD, FKTN, DMD |
intracellular signal transduction (GO:0035556) | 2.39 | 7 | ACTN2, PLN, CRYAB, PSEN1, RAF1, PSEN2, DMD |
negative regulation of programmed cell death (GO:0043069) | 3.02 | 7 | CRYAB, RAF1, ACTC1, PSEN1, LMNA, PSEN2, BAG3 |
positive regulation of catalytic activity (GO:0043085) | 2.4 | 7 | ACTN2, TPM1, TNNT2, PSEN1, RAF1, PSEN2, MYBPC3 |
regulation of membrane potential (GO:0042391) | 3.89 | 6 | ACTN2, PLN, SCN5A, DSG2, PSEN1, DMD |
protein localization (GO:0008104) | 2.36 | 6 | CSRP3, LMNA, VCL, PSEN1, RAF1, DMD |
negative regulation of metabolic process (GO:0009892) | 1.93 | 6 | CRYAB, PRDM16, RAF1, PSEN1, FKTN, DMD |
positive regulation of metabolic process (GO:0009893) | 1.74 | 6 | CSRP3, PRDM16, ACTC1, PSEN1, RAF1, RBM20 |
negative regulation of response to stimulus (GO:0048585) | 2.52 | 6 | PRDM16, RAF1, PSEN1, LMNA, FKTN, DMD |
cell differentiation (GO:0030154) | 2.14 | 6 | CSRP3, PRDM16, LAMA4, PSEN1, TNNI3, RAF1 |
homeostatic process (GO:0042592) | 2.61 | 6 | PLN, CSRP3, PSEN1, TNNI3, RAF1, DMD |
negative regulation of signaling (GO:0023057) | 2.65 | 6 | PRDM16, RAF1, PSEN1, LMNA, FKTN, DMD |
regulation of striated muscle contraction (GO:0006942) | 5.38 | 6 | PLN, SCN5A, MYH7, DSG2, DMD, MYBPC3 |
negative regulation of cell communication (GO:0010648) | 2.66 | 6 | PRDM16, RAF1, PSEN1, LMNA, FKTN, DMD |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 6 | PLN, PSEN1, MYH6, RAF1, PSEN2, BAG3 |
negative regulation of catalytic activity (GO:0043086) | 3.0 | 6 | PLN, CRYAB, TNNT2, PSEN1, TNNI3, RAF1 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 6 | EYA4, PRDM16, MYH7, MYH6, RAF1, RBM20 |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 6 | EYA4, PRDM16, MYH7, MYH6, RAF1, RBM20 |
organelle assembly (GO:0070925) | 3.75 | 6 | CSRP3, TTN, ACTC1, MYH6, PSEN1, DMD |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 6 | CRYAB, PRDM16, RAF1, PSEN1, FKTN, DMD |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 6 | CSRP3, PRDM16, ACTC1, PSEN1, RAF1, RBM20 |
negative regulation of signal transduction (GO:0009968) | 2.75 | 6 | PRDM16, RAF1, PSEN1, LMNA, FKTN, DMD |
regulation of protein metabolic process (GO:0051246) | 1.93 | 6 | CRYAB, RAF1, TTN, PSEN1, FKTN, DMD |
response to mechanical stimulus (GO:0009612) | 4.41 | 6 | CSRP3, LMNA, TTN, RAF1, DMD, BAG3 |
regulation of cell motility (GO:2000145) | 3.16 | 6 | TPM1, LMNA, LAMA4, VCL, RAF1, NEXN |
macromolecule localization (GO:0033036) | 2.34 | 6 | CSRP3, LMNA, VCL, PSEN1, RAF1, DMD |
anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 6 | CSRP3, TTN, ACTC1, MYH6, PSEN1, DMD |
cellular homeostasis (GO:0019725) | 3.23 | 6 | PLN, CSRP3, PSEN1, TNNI3, RAF1, DMD |
striated muscle cell development (GO:0055002) | 5.42 | 6 | ACTN2, TTN, MYH6, LMNA, DMD, NEXN |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 6 | CRYAB, PRDM16, RAF1, PSEN1, FKTN, DMD |
regulation of actin filament-based movement (GO:1903115) | 6.33 | 6 | PLN, SCN5A, TNNC1, DSG2, TNNT2, MYBPC3 |
ion transport (GO:0006811) | 2.66 | 6 | PLN, SCN5A, PSEN1, ABCC9, RAF1, PSEN2 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 6 | EYA4, PRDM16, MYH7, MYH6, RAF1, RBM20 |
single-organism transport (GO:0044765) | 2.18 | 6 | ACTN2, LMNA, TTN, VCL, RAF1, ABCC9 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 6 | CRYAB, RAF1, TTN, PSEN1, FKTN, DMD |
sarcomere organization (GO:0045214) | 6.4 | 6 | ACTN2, TPM1, TTN, MYPN, MYH6, LDB3 |
cell adhesion (GO:0007155) | 2.82 | 6 | ACTN2, LAMA4, PSEN1, DSG2, VCL, MYBPC3 |
response to inorganic substance (GO:0010035) | 3.56 | 6 | PLN, CRYAB, SCN5A, TTN, TNNC1, TNNT2 |
single-organism localization (GO:1902578) | 2.09 | 6 | ACTN2, LMNA, TTN, VCL, RAF1, ABCC9 |
heterocycle metabolic process (GO:0046483) | 1.31 | 6 | EYA4, PRDM16, MYH7, MYH6, RAF1, RBM20 |
heart development (GO:0007507) | 4.24 | 6 | MYH7, PSEN1, TNNI3, MYH6, RAF1, RBM20 |
regulation of locomotion (GO:0040012) | 3.12 | 6 | TPM1, LMNA, LAMA4, VCL, RAF1, NEXN |
biological adhesion (GO:0022610) | 2.81 | 6 | ACTN2, LAMA4, PSEN1, DSG2, VCL, MYBPC3 |
regulation of cell differentiation (GO:0045595) | 2.42 | 6 | CSRP3, PRDM16, PSEN1, LMNA, RAF1, DMD |
positive regulation of gene expression (GO:0010628) | 2.35 | 6 | CSRP3, PRDM16, ACTC1, PSEN1, RAF1, RBM20 |
regulation of multicellular organismal development (GO:2000026) | 2.31 | 6 | PRDM16, LAMA4, PSEN1, MYH6, LMNA, DMD |
cardiac muscle cell development (GO:0055013) | 6.4 | 5 | ACTN2, TTN, NEXN, MYH6, LMNA |
regulation of intracellular transport (GO:0032386) | 3.58 | 5 | PLN, TNNC1, CRYAB, TNNT2, MYBPC3 |
cellular component assembly involved in morphogenesis (GO:0010927) | 4.29 | 5 | TTN, CSRP3, ACTC1, DMD, MYH6 |
striated muscle tissue development (GO:0014706) | 5.23 | 5 | PLN, CSRP3, DMD, SGCD, DSG2 |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 5 | TTN, FKTN, DMD, RAF1, PSEN1 |
cell death (GO:0008219) | 3.05 | 5 | CRYAB, ACTC1, RAF1, PSEN1, BAG3 |
negative regulation of protein metabolic process (GO:0051248) | 2.82 | 5 | FKTN, DMD, RAF1, CRYAB, PSEN1 |
negative regulation of hydrolase activity (GO:0051346) | 3.74 | 5 | PLN, TNNI3, CRYAB, TNNT2, RAF1 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 5 | DMD, SCN5A, LMNA, PSEN1, TPM1 |
regulation of protein modification process (GO:0031399) | 2.32 | 5 | TTN, FKTN, DMD, PSEN1, RAF1 |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 5 | RBM20, CSRP3, RAF1, PSEN1, PRDM16 |
response to oxygen-containing compound (GO:1901700) | 2.57 | 5 | PLN, CRYAB, ACTC1, TPM1, DSG2 |
regulation of cell migration (GO:0030334) | 3.23 | 5 | LAMA4, NEXN, VCL, LMNA, TPM1 |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 5 | RBM20, CSRP3, PSEN1, RAF1, PRDM16 |
cardiac cell development (GO:0055006) | 6.33 | 5 | ACTN2, TTN, NEXN, MYH6, LMNA |
cation transport (GO:0006812) | 3.11 | 5 | PSEN2, ABCC9, SCN5A, PSEN1, PLN |
apoptotic process (GO:0006915) | 3.14 | 5 | ACTC1, CRYAB, PSEN1, RAF1, BAG3 |
tissue development (GO:0009888) | 3.27 | 5 | PLN, CSRP3, DMD, SGCD, DSG2 |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 5 | TTN, FKTN, DMD, PSEN1, RAF1 |
programmed cell death (GO:0012501) | 3.1 | 5 | CRYAB, RAF1, ACTC1, PSEN1, BAG3 |
metal ion transport (GO:0030001) | 3.36 | 5 | PLN, ABCC9, SCN5A, PSEN1, PSEN2 |
response to metal ion (GO:0010038) | 3.91 | 5 | PLN, TNNT2, SCN5A, TTN, TNNC1 |
positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 5 | RBM20, CSRP3, RAF1, PSEN1, PRDM16 |
cellular chemical homeostasis (GO:0055082) | 3.4 | 5 | PLN, TNNI3, CSRP3, RAF1, PSEN1 |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 5 | PLN, FKTN, DMD, RAF1, PSEN1 |
regulation of phosphorylation (GO:0042325) | 2.5 | 5 | TTN, FKTN, DMD, RAF1, PSEN1 |
positive regulation of cell differentiation (GO:0045597) | 3.01 | 5 | CSRP3, DMD, PSEN1, LMNA, PRDM16 |
negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 5 | FKTN, CRYAB, RAF1, DMD, PSEN1 |
organonitrogen compound metabolic process (GO:1901564) | 2.32 | 5 | PSEN2, DMD, MYH7, PSEN1, MYH6 |
positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 5 | RBM20, CSRP3, PSEN1, RAF1, PRDM16 |
chemical homeostasis (GO:0048878) | 2.97 | 5 | PLN, TNNI3, CSRP3, RAF1, PSEN1 |
regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 5 | CSRP3, PSEN1, RAF1, PRDM16, MYH6 |
cellular response to stress (GO:0033554) | 2.51 | 5 | TPM1, EYA4, CRYAB, PSEN1, LMNA |
muscle tissue development (GO:0060537) | 5.1 | 5 | PLN, CSRP3, DMD, SGCD, DSG2 |
regulation of protein phosphorylation (GO:0001932) | 2.57 | 5 | TTN, FKTN, DMD, PSEN1, RAF1 |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 4 | ACTN2, DMD, TPM1, PSEN1 |
positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 4 | CSRP3, PSEN1, RAF1, PRDM16 |
negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 4 | PLN, PSEN1, LMNA, PRDM16 |
regulation of organelle organization (GO:0033043) | 2.72 | 4 | ACTN2, TPM1, NEXN, LMNA |
cell projection organization (GO:0030030) | 3.14 | 4 | ACTN2, DMD, TPM1, VCL |
phosphorylation (GO:0016310) | 2.63 | 4 | ACTN2, TTN, CRYAB, RAF1 |
ion homeostasis (GO:0050801) | 3.42 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
nucleic acid metabolic process (GO:0090304) | 1.46 | 4 | RBM20, EYA4, RAF1, PRDM16 |
secretion by cell (GO:0032940) | 3.59 | 4 | ACTN2, TTN, RAF1, VCL |
circulatory system process (GO:0003013) | 4.38 | 4 | TNNI3, PLN, SGCD, ACTC1 |
positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 4 | CSRP3, RAF1, PSEN1, PRDM16 |
calcium ion homeostasis (GO:0055074) | 3.97 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
inorganic ion homeostasis (GO:0098771) | 3.43 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
regulation of ion transmembrane transport (GO:0034765) | 3.77 | 4 | PLN, ACTN2, DMD, SCN5A |
response to hypoxia (GO:0001666) | 4.13 | 4 | PSEN2, CRYAB, LMNA, RAF1 |
multicellular organism development (GO:0007275) | 2.54 | 4 | EYA4, CSRP3, MYH6, TPM1 |
regulation of transmembrane transport (GO:0034762) | 3.74 | 4 | ACTN2, PLN, DMD, SCN5A |
regulation of MAPK cascade (GO:0043408) | 3.22 | 4 | FKTN, DMD, RAF1, PSEN1 |
response to muscle stretch (GO:0035994) | 6.78 | 4 | TTN, DMD, CSRP3, RAF1 |
divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
positive regulation of hydrolase activity (GO:0051345) | 2.91 | 4 | ACTN2, MYBPC3, TNNT2, TPM1 |
cellular macromolecule localization (GO:0070727) | 3.1 | 4 | CSRP3, DMD, VCL, LMNA |
positive regulation of biosynthetic process (GO:0009891) | 2.29 | 4 | CSRP3, PSEN1, RAF1, PRDM16 |
regulation of cardiac muscle contraction (GO:0055117) | 5.57 | 4 | PLN, DMD, SCN5A, DSG2 |
regulation of the force of heart contraction (GO:0002026) | 6.4 | 4 | PLN, CSRP3, MYH7, MYH6 |
negative regulation of developmental process (GO:0051093) | 3.17 | 4 | CSRP3, PSEN1, LMNA, PRDM16 |
regulation of ion transport (GO:0043269) | 3.4 | 4 | ACTN2, PLN, DMD, SCN5A |
cellular localization (GO:0051641) | 2.32 | 4 | CSRP3, DMD, VCL, LMNA |
regulation of receptor activity (GO:0010469) | 4.98 | 4 | ACTN2, PLN, DMD, PSEN1 |
regulation of cell proliferation (GO:0042127) | 2.41 | 4 | TPM1, SCN5A, FKTN, RAF1 |
cardiac muscle tissue development (GO:0048738) | 6.33 | 4 | PLN, CSRP3, SGCD, DSG2 |
protein phosphorylation (GO:0006468) | 2.89 | 4 | TTN, ACTN2, CRYAB, RAF1 |
myofibril assembly (GO:0030239) | 6.43 | 4 | TTN, CSRP3, ACTC1, MYH6 |
cellular metal ion homeostasis (GO:0006875) | 3.75 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
cellular calcium ion homeostasis (GO:0006874) | 4.01 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
cellular protein localization (GO:0034613) | 3.11 | 4 | CSRP3, DMD, LMNA, VCL |
cellular ion homeostasis (GO:0006873) | 3.57 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
regulation of metal ion transport (GO:0010959) | 3.94 | 4 | PLN, ACTN2, DMD, SCN5A |
ion transmembrane transport (GO:0034220) | 3.08 | 4 | ABCC9, SCN5A, RAF1, PSEN1 |
positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 4 | CSRP3, PSEN1, RAF1, PRDM16 |
cellular cation homeostasis (GO:0030003) | 3.6 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
metal ion homeostasis (GO:0055065) | 3.61 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
cation homeostasis (GO:0055080) | 3.46 | 4 | PLN, TNNI3, CSRP3, PSEN1 |
response to organic substance (GO:0010033) | 2.2 | 4 | PLN, CRYAB, ACTC1, DSG2 |
response to oxygen levels (GO:0070482) | 4.02 | 4 | PSEN2, CRYAB, RAF1, LMNA |
protein oligomerization (GO:0051259) | 3.71 | 4 | PLN, ACTN2, CRYAB, TNNT2 |
establishment of protein localization (GO:0045184) | 2.53 | 4 | ACTN2, PSEN1, RAF1, LMNA |
secretion (GO:0046903) | 3.38 | 4 | TTN, ACTN2, VCL, RAF1 |
transmembrane transport (GO:0055085) | 2.72 | 4 | ABCC9, SCN5A, RAF1, PSEN1 |
positive regulation of developmental process (GO:0051094) | 2.77 | 4 | CSRP3, PSEN1, DMD, LMNA |
muscle fiber development (GO:0048747) | 5.8 | 4 | TTN, DMD, NEXN, MYH6 |
response to decreased oxygen levels (GO:0036293) | 4.09 | 4 | PSEN2, CRYAB, RAF1, LMNA |
regulation of response to stress (GO:0080134) | 2.53 | 4 | FKTN, CRYAB, RAF1, BAG3 |
regulation of cation transmembrane transport (GO:1904062) | 4.4 | 4 | ACTN2, PLN, DMD, SCN5A |
positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 4 | CSRP3, PSEN1, RAF1, PRDM16 |
positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 4 | CSRP3, RAF1, PSEN1, PRDM16 |
negative regulation of apoptotic signaling pathway (GO:2001234) | 4.42 | 3 | RAF1, PSEN1, LMNA |
regulation of kinase activity (GO:0043549) | 3.07 | 3 | TTN, RAF1, PSEN1 |
single organismal cell-cell adhesion (GO:0016337) | 3.69 | 3 | VCL, PSEN1, DSG2 |
positive regulation of transport (GO:0051050) | 2.9 | 3 | ACTN2, DMD, SCN5A |
regulation of cardiac conduction (GO:1903779) | 5.57 | 3 | PLN, ABCC9, TNNI3 |
regulation of apoptotic signaling pathway (GO:2001233) | 3.83 | 3 | RAF1, PSEN1, LMNA |
regulation of cytoskeleton organization (GO:0051493) | 3.72 | 3 | ACTN2, TPM1, NEXN |
regulation of cell adhesion (GO:0030155) | 3.27 | 3 | DMD, LAMA4, TPM1 |
cell junction organization (GO:0034330) | 4.51 | 3 | ACTN2, VCL, DSG2 |
negative regulation of proteolysis (GO:0045861) | 3.98 | 3 | CRYAB, PSEN1, RAF1 |
negative regulation of cellular component organization (GO:0051129) | 3.35 | 3 | RAF1, PSEN1, LMNA |
regulation of homeostatic process (GO:0032844) | 3.65 | 3 | PLN, DMD, SCN5A |
cellular biosynthetic process (GO:0044249) | 1.37 | 3 | EYA4, DMD, PRDM16 |
negative regulation of gene expression (GO:0010629) | 2.48 | 3 | CRYAB, PSEN1, PRDM16 |
single organism cell adhesion (GO:0098602) | 3.63 | 3 | VCL, PSEN1, DSG2 |
cellular macromolecular complex assembly (GO:0034622) | 3.18 | 3 | TTN, DMD, CRYAB |
small molecule metabolic process (GO:0044281) | 2.38 | 3 | MYH7, MYH6, SDHA |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 3 | TPM1, SCN5A, LMNA |
enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 3 | PSEN2, RAF1, MYH6 |
response to calcium ion (GO:0051592) | 4.98 | 3 | TTN, SCN5A, TNNT2 |
response to organic cyclic compound (GO:0014070) | 3.07 | 3 | PLN, CRYAB, DSG2 |
regulation of cardiac muscle cell contraction (GO:0086004) | 6.51 | 3 | PLN, SCN5A, DSG2 |
organic substance biosynthetic process (GO:1901576) | 1.34 | 3 | EYA4, DMD, PRDM16 |
Notch signaling pathway (GO:0007219) | 4.99 | 3 | PLN, PSEN2, PSEN1 |
regulation of ion transmembrane transporter activity (GO:0032412) | 4.55 | 3 | ACTN2, PLN, DMD |
cardiac conduction (GO:0061337) | 5.54 | 3 | PLN, SCN5A, DSG2 |
response to lipid (GO:0033993) | 3.11 | 3 | PLN, CRYAB, DSG2 |
platelet degranulation (GO:0002576) | 5.12 | 3 | ACTN2, TTN, VCL |
exocytosis (GO:0006887) | 4.11 | 3 | ACTN2, TTN, VCL |
MAPK cascade (GO:0000165) | 3.91 | 3 | ACTN2, CRYAB, RAF1 |
regulated exocytosis (GO:0045055) | 4.44 | 3 | ACTN2, TTN, VCL |
negative regulation of ATPase activity (GO:0032780) | 7.16 | 3 | PLN, TNNI3, TNNT2 |
regulation of transporter activity (GO:0032409) | 4.45 | 3 | PLN, ACTN2, DMD |
regulation of immune system process (GO:0002682) | 2.5 | 3 | RAF1, PSEN1, PRDM16 |
signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 3 | ACTN2, CRYAB, RAF1 |
cell projection assembly (GO:0030031) | 4.19 | 3 | ACTN2, DMD, VCL |
actin filament organization (GO:0007015) | 4.54 | 3 | TTN, TNNT2, ACTC1 |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 3 | EYA4, DMD, PRDM16 |
inorganic cation transmembrane transport (GO:0098662) | 3.55 | 3 | ABCC9, SCN5A, PSEN1 |
negative regulation of cell proliferation (GO:0008285) | 3.26 | 3 | TPM1, FKTN, RAF1 |
organ morphogenesis (GO:0009887) | 3.55 | 3 | MYBPC3, SCN5A, PSEN1 |
cardiac myofibril assembly (GO:0055003) | 7.02 | 3 | TTN, CSRP3, ACTC1 |
negative regulation of protein phosphorylation (GO:0001933) | 3.79 | 3 | DMD, FKTN, PSEN1 |
negative regulation of transport (GO:0051051) | 3.6 | 3 | ACTN2, PLN, CRYAB |
negative regulation of phosphate metabolic process (GO:0045936) | 3.45 | 3 | DMD, FKTN, PSEN1 |
cell-cell adhesion (GO:0098609) | 3.34 | 3 | VCL, PSEN1, DSG2 |
neurological system process (GO:0050877) | 2.64 | 3 | TNNI3, EYA4, PSEN1 |
regulation of muscle filament sliding (GO:0032971) | 8.34 | 3 | TNNC1, MYBPC3, TNNT2 |
regulation of protein kinase activity (GO:0045859) | 3.15 | 3 | TTN, RAF1, PSEN1 |
calcium ion transport (GO:0006816) | 4.33 | 3 | PSEN2, PLN, PSEN1 |
protein homooligomerization (GO:0051260) | 4.21 | 3 | PLN, ACTN2, CRYAB |
negative regulation of phosphorus metabolic process (GO:0010563) | 3.45 | 3 | DMD, FKTN, PSEN1 |
positive regulation of ion transport (GO:0043270) | 4.36 | 3 | ACTN2, DMD, SCN5A |
negative regulation of cell differentiation (GO:0045596) | 3.33 | 3 | CSRP3, PSEN1, PRDM16 |
biosynthetic process (GO:0009058) | 1.32 | 3 | EYA4, DMD, PRDM16 |
regulation of proteolysis (GO:0030162) | 3.2 | 3 | CRYAB, PSEN1, RAF1 |
organic substance transport (GO:0071702) | 2.15 | 3 | PSEN1, RAF1, LMNA |
cell-cell junction organization (GO:0045216) | 4.66 | 3 | ACTN2, VCL, DSG2 |
regulation of cation channel activity (GO:2001257) | 5.27 | 3 | ACTN2, PLN, DMD |
divalent metal ion transport (GO:0070838) | 4.15 | 3 | PLN, PSEN2, PSEN1 |
cellular protein complex assembly (GO:0043623) | 3.9 | 3 | TTN, CRYAB, DMD |
response to oxidative stress (GO:0006979) | 3.9 | 3 | CRYAB, TPM1, PSEN1 |
skeletal muscle contraction (GO:0003009) | 6.33 | 3 | TNNI3, TNNC1, MYH7 |
RNA metabolic process (GO:0016070) | 1.59 | 3 | EYA4, RBM20, PRDM16 |
single organism signaling (GO:0044700) | 3.25 | 3 | PLN, SCN5A, DSG2 |
negative regulation of phosphorylation (GO:0042326) | 3.7 | 3 | DMD, FKTN, PSEN1 |
divalent inorganic cation transport (GO:0072511) | 4.13 | 3 | PSEN2, PLN, PSEN1 |
vesicle-mediated transport (GO:0016192) | 2.72 | 3 | ACTN2, TTN, VCL |
cellular amide metabolic process (GO:0043603) | 3.23 | 3 | PSEN2, DMD, PSEN1 |
heart contraction (GO:0060047) | 7.02 | 3 | TNNI3, SGCD, ACTC1 |
regulation of transmembrane transporter activity (GO:0022898) | 4.52 | 3 | ACTN2, PLN, DMD |
negative regulation of protein modification process (GO:0031400) | 3.4 | 3 | DMD, FKTN, PSEN1 |
regulation of cellular response to stress (GO:0080135) | 3.4 | 3 | CRYAB, FKTN, BAG3 |
inorganic ion transmembrane transport (GO:0098660) | 3.38 | 3 | ABCC9, SCN5A, PSEN1 |
regulation of transferase activity (GO:0051338) | 2.88 | 3 | TTN, RAF1, PSEN1 |
immune system process (GO:0002376) | 2.29 | 3 | ABCC9, RAF1, PSEN1 |
cardiac muscle fiber development (GO:0048739) | 7.65 | 3 | TTN, NEXN, MYH6 |
multicellular organismal signaling (GO:0035637) | 5.36 | 3 | PLN, SCN5A, DSG2 |
regulation of ion homeostasis (GO:2000021) | 4.44 | 3 | PLN, DMD, SCN5A |
positive regulation of ATPase activity (GO:0032781) | 5.99 | 3 | MYBPC3, TNNT2, TPM1 |
protein transport (GO:0015031) | 2.62 | 3 | RAF1, PSEN1, LMNA |
signaling (GO:0023052) | 3.25 | 3 | PLN, SCN5A, DSG2 |
peptide metabolic process (GO:0006518) | 3.44 | 3 | PSEN2, DMD, PSEN1 |
cation transmembrane transport (GO:0098655) | 3.43 | 3 | ABCC9, SCN5A, PSEN1 |
heart process (GO:0003015) | 7.02 | 3 | TNNI3, SGCD, ACTC1 |
regulation of extrinsic apoptotic signaling pathway (GO:2001236) | 4.69 | 2 | RAF1, LMNA |
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237) | 5.13 | 2 | RAF1, LMNA |
detection of external stimulus (GO:0009581) | 4.98 | 2 | TTN, CSRP3 |
protein dephosphorylation (GO:0006470) | 4.47 | 2 | EYA4, MYH6 |
negative regulation of intracellular transport (GO:0032387) | 5.02 | 2 | PLN, CRYAB |
regulation of sequestering of calcium ion (GO:0051282) | 5.07 | 2 | PLN, DMD |
activation of protein kinase activity (GO:0032147) | 4.08 | 2 | RAF1, PSEN1 |
regulation of calcium-mediated signaling (GO:0050848) | 5.41 | 2 | PLN, DMD |
purine ribonucleoside monophosphate metabolic process (GO:0009167) | 4.7 | 2 | MYH7, MYH6 |
anion transport (GO:0006820) | 3.71 | 2 | ABCC9, PSEN1 |
ribonucleoside monophosphate metabolic process (GO:0009161) | 4.62 | 2 | MYH7, MYH6 |
action potential (GO:0001508) | 5.42 | 2 | DMD, SCN5A |
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 3.54 | 2 | PSEN2, RAF1 |
negative regulation of ion transmembrane transport (GO:0034766) | 5.47 | 2 | ACTN2, PLN |
positive regulation of ion transmembrane transport (GO:0034767) | 5.05 | 2 | ACTN2, DMD |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 2 | EYA4, PRDM16 |
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114) | 3.79 | 2 | MYH6, PSEN1 |
positive regulation of cell projection organization (GO:0031346) | 3.99 | 2 | DMD, PSEN1 |
nitrogen compound transport (GO:0071705) | 3.54 | 2 | RAF1, PSEN1 |
positive regulation of cell adhesion (GO:0045785) | 3.79 | 2 | DMD, TPM1 |
positive regulation of signal transduction (GO:0009967) | 2.5 | 2 | RAF1, PSEN1 |
positive regulation of cytoskeleton organization (GO:0051495) | 4.58 | 2 | ACTN2, TPM1 |
skeletal muscle tissue development (GO:0007519) | 5.65 | 2 | CSRP3, DMD |
response to wounding (GO:0009611) | 4.39 | 2 | TPM1, RAF1 |
peptidyl-amino acid modification (GO:0018193) | 2.98 | 2 | TTN, PRDM16 |
regulation of calcium ion import (GO:0090279) | 5.08 | 2 | PLN, DMD |
regulation of neuron differentiation (GO:0045664) | 3.39 | 2 | DMD, PSEN1 |
ribonucleoside triphosphate metabolic process (GO:0009199) | 4.77 | 2 | MYH7, MYH6 |
positive regulation of neuron differentiation (GO:0045666) | 3.98 | 2 | DMD, PSEN1 |
positive regulation of cell development (GO:0010720) | 3.57 | 2 | DMD, PSEN1 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281) | 4.43 | 2 | CRYAB, RAF1 |
regulation of calcium ion transport into cytosol (GO:0010522) | 5.23 | 2 | PLN, DMD |
regulation of sodium ion transmembrane transport (GO:1902305) | 5.86 | 2 | DMD, SCN5A |
purine ribonucleoside triphosphate metabolic process (GO:0009205) | 4.81 | 2 | MYH7, MYH6 |
positive regulation of response to stimulus (GO:0048584) | 2.18 | 2 | RAF1, PSEN1 |
calcium-mediated signaling (GO:0019722) | 5.24 | 2 | PLN, DMD |
ATP metabolic process (GO:0046034) | 4.98 | 2 | MYH7, MYH6 |
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 6.51 | 2 | PLN, DMD |
single organism reproductive process (GO:0044702) | 2.73 | 2 | LMNA, DSG2 |
positive regulation of neuron projection development (GO:0010976) | 4.26 | 2 | DMD, PSEN1 |
regulation of neuron projection development (GO:0010975) | 3.69 | 2 | DMD, PSEN1 |
purine ribonucleoside metabolic process (GO:0046128) | 4.33 | 2 | MYH7, MYH6 |
negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 2 | PSEN1, PRDM16 |
stem cell population maintenance (GO:0019827) | 4.83 | 2 | RAF1, PRDM16 |
positive regulation of phosphorylation (GO:0042327) | 2.9 | 2 | RAF1, PSEN1 |
immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.06 | 2 | RAF1, PSEN1 |
membrane organization (GO:0061024) | 3.04 | 2 | SGCD, LMNA |
intermediate filament cytoskeleton organization (GO:0045104) | 6.04 | 2 | DES, RAF1 |
Wnt signaling pathway (GO:0016055) | 3.88 | 2 | MYH6, PSEN1 |
positive regulation of organelle organization (GO:0010638) | 3.38 | 2 | ACTN2, TPM1 |
intermediate filament-based process (GO:0045103) | 6.02 | 2 | DES, RAF1 |
purine nucleotide metabolic process (GO:0006163) | 4.09 | 2 | MYH7, MYH6 |
detection of mechanical stimulus (GO:0050982) | 5.94 | 2 | TTN, CSRP3 |
positive regulation of heart contraction (GO:0045823) | 6.15 | 2 | TPM1, SCN5A |
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.68 | 2 | PLN, DMD |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881) | 6.9 | 2 | PLN, DMD |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.59 | 2 | PLN, DMD |
organophosphate metabolic process (GO:0019637) | 3.04 | 2 | MYH7, MYH6 |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 2 | EYA4, PRDM16 |
positive regulation of cation transmembrane transport (GO:1904064) | 5.17 | 2 | ACTN2, DMD |
morphogenesis of an epithelium (GO:0002009) | 4.08 | 2 | VCL, PSEN1 |
positive regulation of ion transmembrane transporter activity (GO:0032414) | 5.55 | 2 | ACTN2, DMD |
negative regulation of transporter activity (GO:0032410) | 5.59 | 2 | PLN, ACTN2 |
regulation of skeletal muscle contraction (GO:0014819) | 7.33 | 2 | DMD, MYH7 |
negative regulation of biosynthetic process (GO:0009890) | 2.47 | 2 | PSEN1, PRDM16 |
regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 2 | TPM1, PSEN1 |
nucleoside triphosphate metabolic process (GO:0009141) | 4.61 | 2 | MYH7, MYH6 |
purine nucleoside triphosphate metabolic process (GO:0009144) | 4.76 | 2 | MYH7, MYH6 |
response to reactive oxygen species (GO:0000302) | 4.5 | 2 | CRYAB, TPM1 |
negative regulation of cellular component movement (GO:0051271) | 4.22 | 2 | TPM1, VCL |
microtubule cytoskeleton organization (GO:0000226) | 4.13 | 2 | CRYAB, LMNA |
second-messenger-mediated signaling (GO:0019932) | 4.65 | 2 | PLN, DMD |
amyloid precursor protein catabolic process (GO:0042987) | 7.65 | 2 | PSEN2, PSEN1 |
regulation of protein serine/threonine kinase activity (GO:0071900) | 3.58 | 2 | RAF1, PSEN1 |
nucleic acid-templated transcription (GO:0097659) | 1.91 | 2 | EYA4, PRDM16 |
amyloid precursor protein metabolic process (GO:0042982) | 7.24 | 2 | PSEN2, PSEN1 |
detection of muscle stretch (GO:0035995) | 8.34 | 2 | TTN, CSRP3 |
positive regulation of transferase activity (GO:0051347) | 3.31 | 2 | RAF1, PSEN1 |
immune response-regulating signaling pathway (GO:0002764) | 3.72 | 2 | RAF1, PSEN1 |
immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.96 | 2 | RAF1, PSEN1 |
blood vessel development (GO:0001568) | 4.95 | 2 | LAMA4, PSEN1 |
regulation of cell projection organization (GO:0031344) | 3.38 | 2 | DMD, PSEN1 |
positive regulation of immune system process (GO:0002684) | 2.96 | 2 | RAF1, PSEN1 |
homotypic cell-cell adhesion (GO:0034109) | 5.76 | 2 | VCL, DSG2 |
negative regulation of intracellular signal transduction (GO:1902532) | 3.63 | 2 | DMD, FKTN |
cellular response to abiotic stimulus (GO:0071214) | 4.15 | 2 | CRYAB, BAG3 |
G-protein coupled receptor signaling pathway (GO:0007186) | 2.64 | 2 | ACTN2, PLN |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 2 | EYA4, PRDM16 |
regulation of cellular component biogenesis (GO:0044087) | 3.08 | 2 | TPM1, RAF1 |
positive regulation of transmembrane transport (GO:0034764) | 4.99 | 2 | ACTN2, DMD |
wound healing (GO:0042060) | 5.13 | 2 | TPM1, RAF1 |
purine ribonucleotide metabolic process (GO:0009150) | 4.16 | 2 | MYH7, MYH6 |
positive regulation of MAPK cascade (GO:0043410) | 3.57 | 2 | RAF1, PSEN1 |
canonical Wnt signaling pathway (GO:0060070) | 5.26 | 2 | MYH6, PSEN1 |
positive regulation of blood circulation (GO:1903524) | 5.16 | 2 | TPM1, SCN5A |
macromolecule glycosylation (GO:0043413) | 4.2 | 2 | FKTN, PSEN1 |
regulation of actin cytoskeleton organization (GO:0032956) | 4.09 | 2 | ACTN2, TPM1 |
somatic stem cell population maintenance (GO:0035019) | 5.52 | 2 | RAF1, PRDM16 |
positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 2 | RAF1, PSEN1 |
positive regulation of nervous system development (GO:0051962) | 3.64 | 2 | DMD, PSEN1 |
negative regulation of peptidase activity (GO:0010466) | 4.22 | 2 | CRYAB, RAF1 |
Notch receptor processing (GO:0007220) | 6.9 | 2 | PSEN2, PSEN1 |
detection of stimulus (GO:0051606) | 3.22 | 2 | TTN, CSRP3 |
brain development (GO:0007420) | 4.24 | 2 | PSEN1, BAG3 |
sensory organ development (GO:0007423) | 4.82 | 2 | CRYAB, PRDM16 |
maintenance of cell number (GO:0098727) | 4.82 | 2 | RAF1, PRDM16 |
positive regulation of protein modification process (GO:0031401) | 2.7 | 2 | RAF1, PSEN1 |
cell activation (GO:0001775) | 3.47 | 2 | RAF1, PSEN1 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154) | 5.29 | 2 | CRYAB, RAF1 |
muscle hypertrophy (GO:0014896) | 6.68 | 2 | TTN, CSRP3 |
striated muscle hypertrophy (GO:0014897) | 6.78 | 2 | TTN, CSRP3 |
transcription, DNA-templated (GO:0006351) | 1.91 | 2 | EYA4, PRDM16 |
negative regulation of cell motility (GO:2000146) | 4.36 | 2 | TPM1, VCL |
nucleoside phosphate metabolic process (GO:0006753) | 3.71 | 2 | MYH7, MYH6 |
positive regulation of kinase activity (GO:0033674) | 3.54 | 2 | RAF1, PSEN1 |
negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 2 | PSEN1, PRDM16 |
regulation of cell morphogenesis (GO:0022604) | 3.4 | 2 | TPM1, PSEN1 |
protein folding (GO:0006457) | 4.32 | 2 | CRYAB, BAG3 |
purine nucleoside metabolic process (GO:0042278) | 4.32 | 2 | MYH7, MYH6 |
RNA biosynthetic process (GO:0032774) | 1.84 | 2 | EYA4, PRDM16 |
dephosphorylation (GO:0016311) | 4.06 | 2 | EYA4, MYH6 |
membrane protein proteolysis (GO:0033619) | 6.17 | 2 | PSEN2, PSEN1 |
regulation of cellular protein localization (GO:1903827) | 3.43 | 2 | ACTN2, LMNA |
single-organism carbohydrate metabolic process (GO:0044723) | 3.42 | 2 | FKTN, PSEN1 |
regulation of MAP kinase activity (GO:0043405) | 3.95 | 2 | RAF1, PSEN1 |
embryo development ending in birth or egg hatching (GO:0009792) | 4.35 | 2 | TPM1, MYH6 |
cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 2 | EYA4, PRDM16 |
nucleoside monophosphate metabolic process (GO:0009123) | 4.54 | 2 | MYH7, MYH6 |
positive regulation of cell communication (GO:0010647) | 2.41 | 2 | RAF1, PSEN1 |
beta-amyloid metabolic process (GO:0050435) | 7.09 | 2 | PSEN2, PSEN1 |
purine nucleoside monophosphate metabolic process (GO:0009126) | 4.69 | 2 | MYH7, MYH6 |
ribonucleotide metabolic process (GO:0009259) | 4.11 | 2 | MYH7, MYH6 |
negative regulation of MAPK cascade (GO:0043409) | 4.74 | 2 | DMD, FKTN |
regulation of protein localization (GO:0032880) | 2.88 | 2 | ACTN2, LMNA |
response to endogenous stimulus (GO:0009719) | 2.79 | 2 | PLN, DSG2 |
regulation of neurogenesis (GO:0050767) | 3.21 | 2 | DMD, PSEN1 |
regulation of cellular response to growth factor stimulus (GO:0090287) | 4.29 | 2 | DMD, PRDM16 |
in utero embryonic development (GO:0001701) | 4.4 | 2 | TPM1, MYH6 |
cardiac muscle cell action potential (GO:0086001) | 6.33 | 2 | DMD, SCN5A |
negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 2 | PSEN1, PRDM16 |
transition between fast and slow fiber (GO:0014883) | 7.78 | 2 | TNNC1, MYH7 |
positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 2 | RAF1, PSEN1 |
negative regulation of ion transmembrane transporter activity (GO:0032413) | 5.74 | 2 | PLN, ACTN2 |
cardiac muscle hypertrophy (GO:0003300) | 6.84 | 2 | TTN, CSRP3 |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | RAF1, PSEN1 |
regulation of cell development (GO:0060284) | 3.01 | 2 | DMD, PSEN1 |
positive regulation of neurogenesis (GO:0050769) | 3.77 | 2 | DMD, PSEN1 |
negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 2 | PSEN1, PRDM16 |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | RAF1, PSEN1 |
regulation of peptidyl-serine phosphorylation (GO:0033135) | 4.98 | 2 | DMD, RAF1 |
membrane protein ectodomain proteolysis (GO:0006509) | 6.64 | 2 | PSEN2, PSEN1 |
proteolysis (GO:0006508) | 2.73 | 2 | PSEN2, PSEN1 |
chordate embryonic development (GO:0043009) | 4.38 | 2 | TPM1, MYH6 |
monovalent inorganic cation transport (GO:0015672) | 3.74 | 2 | ABCC9, SCN5A |
regulation of sodium ion transport (GO:0002028) | 5.4 | 2 | DMD, SCN5A |
positive regulation of sodium ion transport (GO:0010765) | 6.23 | 2 | DMD, SCN5A |
multicellular organismal reproductive process (GO:0048609) | 3.35 | 2 | LMNA, DSG2 |
cell proliferation (GO:0008283) | 3.23 | 2 | RAF1, PSEN1 |
regulation of muscle filament sliding speed (GO:0032972) | 9.04 | 2 | TNNC1, TNNT2 |
brown fat cell differentiation (GO:0050873) | 6.26 | 2 | LAMA4, PRDM16 |
negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 2 | PSEN1, PRDM16 |
cellular response to DNA damage stimulus (GO:0006974) | 3.17 | 2 | EYA4, PSEN1 |
negative regulation of ion transport (GO:0043271) | 4.94 | 2 | ACTN2, PLN |
regulation of skeletal muscle adaptation (GO:0014733) | 7.16 | 2 | TNNC1, MYH7 |
immune response-activating signal transduction (GO:0002757) | 3.8 | 2 | RAF1, PSEN1 |
negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 2 | PSEN1, PRDM16 |
protein processing (GO:0016485) | 4.62 | 2 | PSEN2, PSEN1 |
cell junction assembly (GO:0034329) | 4.86 | 2 | ACTN2, VCL |
nucleobase-containing small molecule metabolic process (GO:0055086) | 3.59 | 2 | MYH7, MYH6 |
regulation of immune response (GO:0050776) | 2.98 | 2 | RAF1, PSEN1 |
protein maturation (GO:0051604) | 4.48 | 2 | PSEN2, PSEN1 |
regulation of cellular response to heat (GO:1900034) | 5.41 | 2 | CRYAB, BAG3 |
carbohydrate derivative metabolic process (GO:1901135) | 3.07 | 2 | MYH7, MYH6 |
regulation of binding (GO:0051098) | 4.08 | 2 | PLN, PSEN1 |
negative regulation of cation transmembrane transport (GO:1904063) | 5.65 | 2 | PLN, ACTN2 |
regulation of heart rate by cardiac conduction (GO:0086091) | 6.33 | 2 | SCN5A, DSG2 |
positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 2 | CSRP3, RAF1 |
protein localization to organelle (GO:0033365) | 3.57 | 2 | CSRP3, LMNA |
system development (GO:0048731) | 2.92 | 2 | FKTN, SDHA |
gland development (GO:0048732) | 4.15 | 2 | RAF1, PSEN1 |
positive regulation of protein kinase activity (GO:0045860) | 3.61 | 2 | RAF1, PSEN1 |
embryo development (GO:0009790) | 4.2 | 2 | TPM1, MYH6 |
activation of MAPKK activity (GO:0000186) | 5.74 | 2 | RAF1, PSEN1 |
adherens junction assembly (GO:0034333) | 6.2 | 2 | ACTN2, VCL |
adherens junction organization (GO:0034332) | 5.48 | 2 | ACTN2, VCL |
skeletal muscle thin filament assembly (GO:0030240) | 8.12 | 2 | TTN, ACTC1 |
mitotic cell cycle process (GO:1903047) | 3.12 | 2 | TTN, LMNA |
regulation of calcium ion transmembrane transport (GO:1903169) | 4.98 | 2 | PLN, DMD |
positive regulation of cell death (GO:0010942) | 3.32 | 2 | PSEN2, PSEN1 |
cell cycle process (GO:0022402) | 2.75 | 2 | TTN, LMNA |
purine-containing compound metabolic process (GO:0072521) | 4.0 | 2 | MYH7, MYH6 |
negative regulation of transmembrane transport (GO:0034763) | 5.38 | 2 | PLN, ACTN2 |
fat cell differentiation (GO:0045444) | 5.02 | 2 | LAMA4, PRDM16 |
regulation of muscle adaptation (GO:0043502) | 5.78 | 2 | TNNC1, MYH7 |
regulation of action potential (GO:0098900) | 6.07 | 2 | SCN5A, DSG2 |
positive regulation of immune response (GO:0050778) | 3.4 | 2 | RAF1, PSEN1 |
protein glycosylation (GO:0006486) | 4.2 | 2 | FKTN, PSEN1 |
glycosyl compound metabolic process (GO:1901657) | 4.04 | 2 | MYH7, MYH6 |
regulation of cysteine-type endopeptidase activity (GO:2000116) | 4.37 | 2 | CRYAB, RAF1 |
negative regulation of cysteine-type endopeptidase activity (GO:2000117) | 5.25 | 2 | CRYAB, RAF1 |
regulation of growth (GO:0040008) | 3.26 | 2 | CRYAB, MYH6 |
negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 2 | PSEN1, PRDM16 |
positive regulation of apoptotic process (GO:0043065) | 3.38 | 2 | PSEN2, PSEN1 |
regulation of nervous system development (GO:0051960) | 3.1 | 2 | DMD, PSEN1 |
positive regulation of heart rate (GO:0010460) | 6.59 | 2 | TPM1, SCN5A |
thymus development (GO:0048538) | 5.88 | 2 | RAF1, PSEN1 |
hematopoietic or lymphoid organ development (GO:0048534) | 4.49 | 2 | RAF1, PSEN1 |
positive regulation of programmed cell death (GO:0043068) | 3.38 | 2 | PSEN2, PSEN1 |
ribonucleoside metabolic process (GO:0009119) | 4.21 | 2 | MYH7, MYH6 |
negative regulation of cell migration (GO:0030336) | 4.41 | 2 | TPM1, VCL |
detection of abiotic stimulus (GO:0009582) | 4.96 | 2 | TTN, CSRP3 |
negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 2 | PSEN1, PRDM16 |
positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 2 | RAF1, PSEN1 |
regulation of peptidase activity (GO:0052547) | 3.75 | 2 | CRYAB, RAF1 |
regulation of endopeptidase activity (GO:0052548) | 3.8 | 2 | CRYAB, RAF1 |
adult heart development (GO:0007512) | 7.16 | 2 | MYH7, MYH6 |
glycosylation (GO:0070085) | 4.16 | 2 | FKTN, PSEN1 |
negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 2 | PSEN1, PRDM16 |
reproductive process (GO:0022414) | 2.55 | 2 | LMNA, DSG2 |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 2 | EYA4, PRDM16 |
nucleotide metabolic process (GO:0009117) | 3.73 | 2 | MYH7, MYH6 |
nucleoside metabolic process (GO:0009116) | 4.12 | 2 | MYH7, MYH6 |
negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 2 | PSEN1, PRDM16 |
establishment of localization in cell (GO:0051649) | 2.47 | 2 | RAF1, LMNA |
negative regulation of endopeptidase activity (GO:0010951) | 4.26 | 2 | CRYAB, RAF1 |
neurogenesis (GO:0022008) | 5.45 | 2 | PSEN1, PRDM16 |
positive regulation of signaling (GO:0023056) | 2.41 | 2 | RAF1, PSEN1 |
positive regulation of transporter activity (GO:0032411) | 5.44 | 2 | ACTN2, DMD |
regulation of calcium ion transmembrane transporter activity (GO:1901019) | 5.49 | 2 | PLN, DMD |
negative regulation of locomotion (GO:0040013) | 4.22 | 2 | TPM1, VCL |
microtubule-based process (GO:0007017) | 3.54 | 2 | CRYAB, LMNA |
carbohydrate metabolic process (GO:0005975) | 3.26 | 2 | FKTN, PSEN1 |
nervous system development (GO:0007399) | 3.53 | 2 | FKTN, SDHA |
regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 5.44 | 2 | PLN, DMD |
regulation of calcium ion transport (GO:0051924) | 4.38 | 2 | PLN, DMD |
ribose phosphate metabolic process (GO:0019693) | 4.06 | 2 | MYH7, MYH6 |
chromatin organization (GO:0006325) | 3.28 | 2 | EYA4, PRDM16 |
response to ketone (GO:1901654) | 4.53 | 2 | PLN, DSG2 |
response to hormone (GO:0009725) | 3.33 | 2 | PLN, DSG2 |
activation of immune response (GO:0002253) | 3.67 | 2 | RAF1, PSEN1 |
immune effector process (GO:0002252) | 3.58 | 2 | ABCC9, PSEN1 |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 2 | EYA4, PRDM16 |
positive regulation of protein phosphorylation (GO:0001934) | 2.95 | 2 | RAF1, PSEN1 |